Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-03

Clinical Trial Update: Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy [Phase 4]

View source ↗

Summary

A Phase 4 trial is comparing ulipristal acetate to a gonadotropin-releasing hormone agonist before laparoscopic myomectomy for uterine fibroids; the current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esmya (ulipristal acetate)
  • Gonadotropin-releasing hormone agonist

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Fibroids | Phase 4 | Status: UNKNOWN